PPARG Antikörper (AA 255-268)

Produktnummer ABIN539466

Produktdetails anti-PPARG Antikörper

Target: PPARG (Peroxisome Proliferator-Activated Receptor gamma (PPARG))

Bindungsspezifität: AA 255-268

Reaktivität: Human, Maus, Ratte, Hund, Kaninchen, Meerschweinchen, Schwein, Hamster, Makake, Nerz, Eichhörnchen, Orang-Utan

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PPARG Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Verwendungszweck: Rabbit polyclonal antibody raised against synthetic peptide of PPARG.

Spezifität: This affinity purified antibody is directed against human PPAR gamma protein. Expect reactivity against human (gamma1 and gamma2), mouse (gamma1 and gamma2), rat, squirrel, orangutan, duck (gamma1), macaque (gamma1-gamma7), boar (gamma1a-1d), mink, guinea pig, rabbit (gamma1 and gamma3), dog and hamster sources based on 100 % homology for the immunogen sequence. No reactivity is expected against other subtypes of PPAR.

Kreuzreaktivität: Hund, Meerschweinchen, Hamster, Human, Makake, Nerz, Maus, Orang-Utan, Schwein, Kaninchen, Ratte, Eichhörnchen

Produktmerkmale: Antibody Reactive Against Synthetic Peptide.

Immunogen: A synthetic peptide corresponding to amino acids 255 -268 of human PPARG.

Anwendungsinformationen

Applikationshinweise: ELISA (1:8000-1:32000)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In 20 mM KH₂PO₄, 150 mM NaCl, pH 7.2 (0.01 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-PPARG Antikörper (ABIN539466)

Lee, Chawla, Urbiztondo, Liao, Boisvert, Evans, Curtiss: "Transcriptional repression of atherogenic inflammation: modulation by PPARdelta." in: Science (New York, N.Y.), Vol. 302, Issue 5644, pp. 453-7, (2003) (PubMed).

Plutzky: "Medicine. PPARs as therapeutic targets: reverse cardiology?" in: Science (New York, N.Y.), Vol. 302, Issue 5644, pp. 406-7, (2003) (PubMed).

Lazar: "Progress in cardiovascular biology: PPAR for the course." in: Nature medicine, Vol. 7, Issue 1, pp. 23-4, (2001) (PubMed).

Chinetti, Fruchart, Staels: "Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation." in: Inflammation research : official journal of the European Histamine Research Society ... [et al.], Vol. 49, Issue 10, pp. 497-505, (2001) (PubMed).

Details zu PPARG

Target: PPARG (Peroxisome Proliferator-Activated Receptor gamma (PPARG))

Andere Bezeichnung: PPAR-gamma (PPARG Produkte)

Synonyme: PPAR gamma antikoerper, PPARg2 antikoerper, PPARG antikoerper, Nr1c3 antikoerper, PPAR-gamma antikoerper, PPAR-gamma2 antikoerper, PPARgamma antikoerper, PPARgamma2 antikoerper, NR1C3 antikoerper, CIMT1 antikoerper, GLM1 antikoerper, PPARG1 antikoerper, PPARG2 antikoerper, xPPAR-gamma antikoerper, PPAR-GAMMA antikoerper, PPARGAMMA antikoerper, peroxisome proliferator-activated receptor gamma antikoerper, peroxisome proliferator activated receptor gamma antikoerper, peroxisome proliferator activated receptor gamma L homeolog antikoerper, PPARG antikoerper, Pparg antikoerper, pparg.L antikoerper

Gen-ID: 5468

Pathways: MAPK Signalweg, Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, Regulation of Lipid Metabolism by PPARalpha, Positive Regulation of Endopeptidase Activity, Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation